Scarica l'app Stockscreener
14.24
0.28%
0.04
Dopo l'orario di chiusura:
14.24
Precedente Chiudi:
$14.20
Aprire:
$14.4
Volume 24 ore:
69,383
Relative Volume:
0.75
Capitalizzazione di mercato:
$183.02M
Reddito:
$16.96M
Utile/perdita netta:
$-23.88M
Rapporto P/E:
-6.7907
EPS:
-2.097
Flusso di cassa netto:
$-20.66M
1 W Prestazione:
+1.06%
1M Prestazione:
-13.17%
6M Prestazione:
-24.42%
1 anno Prestazione:
-26.71%
Intervallo 1D:
$14.10
$14.40
Intervallo di 1 settimana:
$13.75
$14.99
Portata 52W:
$13.54
$21.25
Mediwound Ltd Stock (MDWD) Company Profile
Compare MDWD vs VRTX, REGN, ARGX, ALNY, RVMD
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
MDWD
Mediwound Ltd
|
14.24 | 183.02M | 16.96M | -23.88M | -20.66M | -2.097 |
VRTX
Vertex Pharmaceuticals Inc
|
451.63 | 114.63B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
609.94 | 63.95B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
877.72 | 54.58B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
278.09 | 37.13B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
162.99 | 34.65B | 742.00K | -1.37B | -1.07B | -7.0731 |
Mediwound Ltd Stock (MDWD) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-06-02 | Ripresa | Oppenheimer | Outperform |
| 2025-05-02 | Iniziato | Alliance Global Partners | Buy |
| 2025-02-28 | Iniziato | Craig Hallum | Buy |
| 2024-07-16 | Reiterato | Maxim Group | Buy |
| 2022-12-22 | Iniziato | Maxim Group | Buy |
| 2022-07-18 | Ripresa | Oppenheimer | Outperform |
| 2020-09-23 | Iniziato | BTIG Research | Buy |
| 2016-11-28 | Iniziato | Aegis Capital | Buy |
| 2016-08-17 | Iniziato | Wells Fargo | Outperform |
| 2014-04-16 | Iniziato | Oppenheimer | Outperform |
Mostra tutto
Mediwound Ltd Borsa (MDWD) Ultime notizie
Mediwound Ltd (MDWD) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Mediwound Ltd (MDWD) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Mediwound Ltd (MDWD) Valuation: PE, PB & Fair Value Analysis - TradingKey
Mediwound Ltd (MDWD) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Mediwound Ltd (MDWD) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Mediwound Ltd (MDWD) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Mediwound Ltd (MDWD) Institutional Confidence - TradingKey
Mediwound Ltd (MDWD) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Mediwound Ltd (MDWD) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
MDWD Q1 2026 Earnings: Narrower-Than-Expected Loss Boosts SentimentEarnings Growth Analysis - newsline.com
MDWD Q1 2026 Earnings: Strong Beat on EPS Despite Narrower LossEarnings Per Share - newsline.com
MDWD Q1 2026 Earnings: Significant EPS Beat Drives Positive Sentiment Despite Absent RevenueCost Structure Review - newsline.com
MediWound Ltd. (MDWD) Q1 2026 Earnings: Narrowed Loss Surprises to the UpsideGeographic Revenue Trends - newsline.com
MediWound (MDWD) Sheds 1.87% as Stock Holds Above Key Support LevelAccumulation Line - newsline.com
MediWound Ltd. (MDWD) Retreats 1.87% as Price Tests Support Near $13.47Wave Equality - newsline.com
(MDWD) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
Craig Hallum Forecasts MediWound's Q3 Earnings (NASDAQ:MDWD) - MarketBeat
Maxim Group Issues Negative Estimate for MediWound Earnings - MarketBeat
Insider Buying: Nachum Shamir Acquires 6,000 Shares of MediWound Ltd (MDWD) - GuruFocus
Director at MediWound (MDWD) buys 6,000 ordinary shares in market - Stock Titan
MediWound Ltd. Stock Plummets to New 52-Week Low of $13.58 - Markets Mojo
Insider Buying: David Fox Acquires Shares of MediWound Ltd (MDWD) - GuruFocus
Maxim Group Maintains MediWound(MDWD.US) With Buy Rating, Maintains Target Price $30 - Moomoo
MediWound (MDWD) director buys 3,537 ordinary shares on open market - Stock Titan
MediWound Q1 earnings call highlights - MSN
Director Rubinstein buys MediWound (MDWD) shares and holds multiple options - Stock Titan
MediWound Shares Slide This Week; BARDA Moves in Focus - Bez Kabli
MediWound Ltd. Hits New 52-Week Low at USD 14.14 - MarketsMojo
MediWound (MDWD) Slips 1.58% as Stock Holds Near Critical Support at $13.61Price Momentum Stocks - The Legal Advocate
MediWound (MDWD) Insider Trading Activity 2026 - MarketBeat
5 Stocks Better Than MediWound as Q1 Revenue Declines - HarianBasis.co
A. G. P. Maintains MediWound(MDWD.US) With Buy Rating, Cuts Target Price to $22 - Moomoo
MDWD Maintains Outperform by Oppenheimer -- Price Target Lowered to $32 - GuruFocus
MDWD Reiterates by HC Wainwright & Co. -- Price Target Maintained at $36 - GuruFocus
Oppenheimer Adjusts MediWound Price Target to $32 From $33, Maintains Outperform Rating - Moomoo
Oppenheimer Maintains MediWound(MDWD.US) With Buy Rating, Cuts Target Price to $32 - Moomoo
Will MediWound (NASDAQ:MDWD) Spend Its Cash Wisely? - Yahoo Finance
MediWound Ltd. (NASDAQ:MDWD) Q1 2026 Earnings Call Transcript - Insider Monkey
H.C. Wainwright Maintains MediWound(MDWD.US) With Buy Rating, Maintains Target Price $36 - Moomoo
MediWound: Q1 Earnings Snapshot - AOL.com
MediWound Q1 2026 Earnings Call Transcript - MarketBeat
MediWound (MDWD) Q1 Loss Of US$0.23 Per Share Reinforces Bearish Profitability Narratives - simplywall.st
Q3 2025 Mediwound Ltd Earnings Call Transcript - GuruFocus
Q1 2026 Mediwound Ltd Earnings Call Transcript - GuruFocus
MediWound Ltd (MDWD) Q1 2026 Earnings Call Highlights: Strategic Collaborations and Revenue Challenges - GuruFocus
Oppenheimer lowers MediWound stock price target to $32 on revenue miss - Investing.com UK
Oppenheimer lowers MediWound stock price target to $32 on revenue miss By Investing.com - Investing.com Australia
MediWound Q1 2026 earnings preview - MSN
Mediwound Ltd Azioni (MDWD) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.74%
1.44%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):